Dataset:  -

approved

Приложение 4 на ПЛС от 02.07.2019 г.

Unique identificator:  78bb8ac6-d365-4ebe-8a53-ff25ecdcca67

Description:

Приложение 4 на ПЛС от 02.07.2019 г.

здравеопазване лекарства реимбурсиране

Current version: 1

Displayed version: 1

Format: CSV

  • Created at: 2019-07-08 09:52:54
  • Created by: georgi_sivchev
  • Updated at: 2019-07-08 09:52:54
records per page
Order by:

ПОЗИТИВЕН ЛЕКАРСТВЕН СПИСЪК

Etanercept EU/1/99/126/020 ENBREL, Solution for injection, 50 mg/ml – 1 ml, mg, Pack: 4 pre-filled pens +4 alcohol swabs Pfizer Limited, Обединено Кралство Wyeth Pharmaceuticals New Lane Havant Hampshire, PO9 2NG, Обединено кралство 1263.78 252.76 1516.54 4% 10 1273.78 254.76 1528.54 16% 25 1298.78 259.76 1558.54 НСР-7900/25.01.2016.; НСР-12377/18.04.2017; НСР-15118/26.02.2018( предварително изпълнение) 26.02.2018 02.03.2018 Неактивен 3823
Etanercept EU/1/99/126/020 ENBREL, Solution for injection, 50 mg/ml – 1 ml, mg, Pack: 4 pre-filled pens +4 alcohol swabs Pfizer Limited, Обединено Кралство Wyeth Pharmaceuticals New Lane Havant Hampshire, PO9 2NG, Обединено кралство 1362.37 272.47 1634.84 4% 10 1372.37 274.47 1646.84 16% 25 1397.37 279.47 1676.84 НСР-7900/25.01.2016.; НСР-12377/18.04.2017 03.05.2017 02.06.2017 Неактивен 3823
Etanercept EU/1/99/126/003 ENBREL 25, Powder and solvent for solution for injection, 25, mg, Pack: 4 Pfizer Limited, Обединено Кралство Wyeth Pharmaceuticals, Великобритания 681.18 136.24 817.42 4% 10 691.18 138.24 829.42 16% 25 716.18 143.24 859.42 НСР-8334/26.02.2016; НСР-12836/26.05.2017 10.06.2017 02.07.2017 Неактивен 3361
Etanercept EU/1/99/126/012 ENBREL 25 mg powder and solvent for solution for injection for pediatric use 25 mg/ml - 1 ml x 4 vials + 4 pre-filled syringes + 8 syringes + 20 needles + 24 alcohol swabs, powder and solvent for solution for injection for pediatric use, 25, mg, Pack: 4 Pfizer Limited, Обединено Кралство Wyeth Pharmaceuticals, UK 874.12 174.82 1048.94 4% 10 884.12 176.82 1060.94 16% 25 909.12 181.82 1090.94 оставена без разглеждане жалба до Комисия по прозрачност с решение на Комисия по прозрачност КП-241/28.06.2013; Цената се заличавас решение НСР-2572/24.01.2014 КЦРР-2426/22.02.2013 16.10.2013 16.10.2013 Заличен 2136
Etanercept EU/1/99/126/012 ENBREL 25 mg powder and solvent for solution for injection for pediatric use 25 mg/ml - 1 ml x 4 vials + 4 pre-filled syringes + 8 syringes + 20 needles + 24 alcohol swabs, powder and solvent for solution for injection for pediatric use, 25, mg, Pack: 4 Pfizer Limited, Обединено Кралство Wyeth Pharmaceuticals, UK 926.3 185.26 1111.56 4% 10 936.3 187.26 1123.56 16% 25 961.3 192.26 1153.56 промяна в обстоятелствата КЦPP-1521/25.10.2012 КЦ-316/28.11.2008 19.12.2008 19.12.2008 Неактивен 2136
Etanercept EU/1/99/126/013 ENBREL 25 mg solution for injection in pre-filled syringe 50 mg/ml - 0,5 ml x 4 pre-filled syringes + 8 alcohol swabs, Solution for injection, 25, mg, Pack: 4 Pfizer Limited, Обединено Кралство Wyeth Pharmaceuticals, Великобритания 853.07 170.61 1023.68 4% 10 863.07 172.61 1035.68 16% 25 888.07 177.61 1065.68 оставена без разглеждане жалба до Комисия по прозрачност с решение на Комисия по прозрачност КП-241/28.06.2013; Цената се заличавас решение НСР-2573/24.01.2014 КЦРР-2426/22.02.2013 16.10.2013 16.10.2013 Заличен 2135
Etanercept EU/1/99/126/013 ENBREL 25 mg solution for injection in pre-filled syringe 50 mg/ml - 0,5 ml x 4 pre-filled syringes + 8 alcohol swabs, Solution for injection, 25, mg, Pack: 4 Pfizer Limited, Обединено Кралство Wyeth Pharmaceuticals, Великобритания 926.3 185.26 1111.56 4% 10 936.3 187.26 1123.56 16% 25 961.3 192.26 1153.56 промяна в обстоятелствата КЦPP-1521/25.10.2012 КЦ-316/28.11.2008 19.12.2008 19.12.2008 Неактивен 2135
Etanercept EU/1/99/126/003 ENBREL 25 powder and solvent for solution for injection, 25 mg x 4, Powder and solvent for solution for injection, 25, mg, Pack: 4 Pfizer Limited, Обединено Кралство Wyeth Pharmaceuticals, Великобритания 702.67 140.53 843.2 4% 10 712.67 142.53 855.2 16% 25 737.67 147.53 885.2 НСР-8334/26.02.2016 16.03.2016 16.03.2016 Неактивен 3361
Etanercept EU/1/99/126/003 ENBREL 25 powder and solvent for solution for injection, 25 mg x 4, Powder and solvent for solution for injection, 25, mg, Pack: 4 Pfizer Limited, Обединено Кралство Wyeth Pharmaceuticals, Великобритания 789.12 157.82 946.94 4% 10 799.12 159.82 958.94 16% 25 824.12 164.82 988.94 НСР-5033/17.11.2014 01.12.2014 01.12.2014 Неактивен 3361
Etanercept EU/1/99/126/003 ENBREL 25 powder and solvent for solution for injection, 25 mg x 4, Powder and solvent for solution for injection, 25, mg, Pack: 4 Pfizer Limited, Обединено Кралство Wyeth Pharmaceuticals, Великобритания 874.12 174.82 1048.94 4% 10 884.12 176.82 1060.94 16% 25 909.12 181.82 1090.94 Отхвърлена жалба от Комисия по прозрчаност с решение КП-260/18.12.2013 НСР-73/07.06.2013 16.03.2014 16.03.2014 Неактивен 3361
Etanercept EU/1/99/126/003 ENBREL 25 powder and solvent for solution for injection, 25 mg x 4, Powder and solvent for solution for injection, 25, mg, Pack: 4 Pfizer Limited, Обединено Кралство Wyeth Pharmaceuticals, Великобритания 926.3 185.26 1111.56 4% 10 936.3 187.26 1123.56 16% 25 961.3 192.26 1153.56 промяна в обстоятелствата КЦPP-1521/25.10.2012 КЦ-397/07.01.2009 30.01.2009 30.01.2009 Неактивен 3361
Etanercept EU/1/99/126/020 ENBREL 50 mg solution for injection in pre-filled pen 50 mg/ml – 1 ml x 4 pre-filled pens +4 alcohol swabs, Solution for injection, 50, mg, Pack: 4 Pfizer Limited, Обединено Кралство Wyeth Pharmaceuticals New Lane Havant Hampshire, PO9 2NG, Обединено кралство 1405.36 281.07 1686.43 4% 10 1415.36 283.07 1698.43 16% 25 1440.36 288.07 1728.43 НСР-7900/25.01.2016. 09.02.2016 09.02.2016 Неактивен 3823
Etanercept EU/1/99/126/020 ENBREL 50 mg solution for injection in pre-filled pen 50 mg/ml – 1 ml x 4 pre-filled pens +4 alcohol swabs, Solution for injection, 50, mg, Pack: 4 Pfizer Limited, Обединено Кралство Wyeth Pharmaceuticals New Lane Havant Hampshire, PO9 2NG, Обединено кралство 1561.96 312.39 1874.35 4% 10 1571.96 314.39 1886.35 16% 25 1596.96 319.39 1916.35 НСР-6072/23.04.2015. 08.05.2015 08.05.2015 Неактивен 3823
Etanercept EU/1/99/126/017 ENBREL 50 mg solution for injection in pre-filled syringe 50 mg/ml - 1 ml x 4 pre-filled syringes + 8 alcohol swabs, Solution for injection, 50, mg, Pack: 4 Pfizer Europe MA EEIG, Обединено Кралство Wyeth Pharmaceuticals, UK 1405.36 281.07 1686.43 4% 10 1415.36 283.07 1698.43 16% 25 1440.36 288.07 1728.43 НСР-7813/28.12.2015 13.01.2016 13.01.2016 Неактивен 3736
Etanercept EU/1/99/126/017 ENBREL 50 mg solution for injection in pre-filled syringe 50 mg/ml - 1 ml x 4 pre-filled syringes + 8 alcohol swabs, Solution for injection, 50, mg, Pack: 4 Pfizer Europe MA EEIG, Обединено Кралство Wyeth Pharmaceuticals, UK 1561.96 312.39 1874.35 4% 10 1571.96 314.39 1886.35 16% 25 1596.96 319.39 1916.35 НСР-5949/01.04.2015. 16.04.2015 16.04.2015 Неактивен 3736
Etanercept EU/1/99/126/017 ENBREL 50 mg solution for injection in pre-filled syringe 50 mg/ml - 1 ml x 4 pre-filled syringes + 8 alcohol swabs, Solution for injection, 50, mg, Pack: 4 Pfizer Limited, Обединено Кралство Wyeth Pharmaceuticals, UK 1622.03 324.41 1946.44 4% 10 1632.03 326.41 1958.44 16% 25 1657.03 331.41 1988.44 НСР-3992/30.06.2014 15.07.2014 15.07.2014 Неактивен 3736
Etanercept EU/1/99/126/017 ENBREL 50 mg solution for injection in pre-filled syringe 50 mg/ml - 1 ml x 4 pre-filled syringes + 8 alcohol swabs, Solution for injection, 50, mg, Pack: 4 Pfizer Limited, Обединено Кралство Wyeth Pharmaceuticals, UK 1739.08 347.82 2086.9 4% 10 1749.08 349.82 2098.9 16% 25 1774.08 354.82 2128.9 оставена без разглеждане жалба до Комисия по прозрачност с решение на Комисия по прозрачност КП-241/28.06.2013; КЦРР-2426/22.02.2013 16.10.2013 16.10.2013 Неактивен 3736
Etanercept EU/1/99/126/017 ENBREL 50 mg solution for injection in pre-filled syringe 50 mg/ml - 1 ml x 4 pre-filled syringes + 8 alcohol swabs, Solution for injection, 50, mg, Pack: 4 Pfizer Limited, Обединено Кралство Wyeth Pharmaceuticals, UK 1852.6 370.52 2223.12 4% 10 1862.6 372.52 2235.12 16% 25 1887.6 377.52 2265.12 промяна в обстоятелствата КЦPP-1521/25.10.2012 КЦ-316/28.11.2008 19.12.2008 19.12.2008 Неактивен 3736
Macrogol, combinations 20060822 ENDOFALK, Powder for oral solution, 52.5, g, Pack: 6 Dr. Falk Pharma GmbH, Германия Dr. Falk Pharma GmbH - Germany 14.14 2.83 16.97 6% 0.85 14.99 3 17.99 18% 2.55 17.54 3.51 21.05 Промяна на обстоятелства НСР-13979/25.09.2017; НСР-16103/13.07.2018 КЦРР-1094/26.07.2012; НСР-16104/13.07.2018 02.08.2018 02.08.2018 Активен 1310
Macrogol, combinations 20060822 ENDOFALK, Powder for oral solution, 52.5, g, Pack: 6 Dr. Falk Pharma GmbH, Германия Dr. Falk Pharma GmbH - Germany 10.07 2.01 12.08 6% 0.6 10.67 2.13 12.8 18% 1.81 12.48 2.5 14.98 Промяна на обстоятелства НСР-13979/25.09.2017 КЦРР-1094/26.07.2012 10.08.2012 02.11.2017 Неактивен 1310
Macrogol, combinations 5378/ 13.07.2009 ENDOFALK, Powder for oral solution, 52.5, g, Pack: 6 Dr. Falk Pharma GmbH, Германия Dr. Falk Pharma GmbH - Germany 10.07 2.01 12.08 6% 0.6 10.67 2.13 12.8 18% 1.81 12.48 2.5 14.98 КЦРР-1094/26.07.2012 10.08.2012 10.08.2012 Неактивен 1310
Macrogol, combinations 5378/13.07.2009 ENDOFALK, Powder for oral solution, 52.5, g, Pack: 6 Dr. Falk Pharma GmbH, Германия Dr. Falk Pharma GmbH - Germany 12.3 2.46 14.76 8% 0.98 13.28 2.66 15.94 20% 2.46 15.74 3.15 18.89 КЦ-1412/22.02.2010 10.03.2010 10.03.2010 Неактивен 1310
Cyclophosphamide 20020299 Endoxan, Powder for solution for injection, 500, mg, Pack: 1 Екофарм Груп АД, България Екофарм ЕООД, България 20.73 4.15 24.88 6% 1.24 21.97 4.39 26.36 18% 3.73 25.7 5.14 30.84 НСР-13864/14.09.2017 29.09.2017 02.10.2017 Активен 15853
Cyclophosphamide II-1256/13.12.2007 ENDOXAN, Powder for solution for injection, 200, mg, Pack: 10 Екофарм Груп АД, България Екофарм ЕООД, България 41.46 8.29 49.75 4% 1.66 43.12 8.62 51.74 16% 6.63 49.75 9.95 59.7 промяна обстоятелства НСР-13370/28.07.2017; НСР-13712/01.09.2017 КЦРР-2309/20.02.2013; НСР-15268/16.03.2018 08.03.2013 02.04.2018 Заличен 1666
Cyclophosphamide II-1256/13.12.2007 ENDOXAN, Powder for solution for injection, 200, mg, Pack: 10 Екофарм Груп АД, България Екофарм ЕООД, България 41.46 8.29 49.75 4% 1.66 43.12 8.62 51.74 16% 6.63 49.75 9.95 59.7 промяна обстоятелства НСР-13370/28.07.2017; НСР-13712/01.09.2017 КЦРР-2309/20.02.2013 08.03.2013 02.10.2017 Неактивен 1666
Showing 4151 to 4176 of 15076 entries
Download link in CSV format: Copy
Download link in JSON format: Copy
Download link in XML format: Copy
 

Моля изчакайте